These terms and conditions govern your use of the website alphaminr.com and its related services.
These Terms and Conditions (“Terms”) are a binding contract between you and Alphaminr, (“Alphaminr”, “we”, “us” and “service”). You must agree to and accept the Terms. These Terms include the provisions in this document as well as those in the Privacy Policy. These terms may be modified at any time.
Your subscription will be on a month to month basis and automatically renew every month. You may terminate your subscription at any time through your account.
We will provide you with advance notice of any change in fees.
You represent that you are of legal age to form a binding contract. You are responsible for any
activity associated with your account. The account can be logged in at only one computer at a
time.
The Services are intended for your own individual use. You shall only use the Services in a
manner that complies with all laws. You may not use any automated software, spider or system to
scrape data from Alphaminr.
Alphaminr is not a financial advisor and does not provide financial advice of any kind. The service is provided “As is”. The materials and information accessible through the Service are solely for informational purposes. While we strive to provide good information and data, we make no guarantee or warranty as to its accuracy.
TO THE EXTENT PERMITTED BY APPLICABLE LAW, UNDER NO CIRCUMSTANCES SHALL ALPHAMINR BE LIABLE TO YOU FOR DAMAGES OF ANY KIND, INCLUDING DAMAGES FOR INVESTMENT LOSSES, LOSS OF DATA, OR ACCURACY OF DATA, OR FOR ANY AMOUNT, IN THE AGGREGATE, IN EXCESS OF THE GREATER OF (1) FIFTY DOLLARS OR (2) THE AMOUNTS PAID BY YOU TO ALPHAMINR IN THE SIX MONTH PERIOD PRECEDING THIS APPLICABLE CLAIM. SOME STATES DO NOT ALLOW THE EXCLUSION OR LIMITATION OF INCIDENTAL OR CONSEQUENTIAL OR CERTAIN OTHER DAMAGES, SO THE ABOVE LIMITATION AND EXCLUSIONS MAY NOT APPLY TO YOU.
If any provision of these Terms is found to be invalid under any applicable law, such provision shall not affect the validity or enforceability of the remaining provisions herein.
This privacy policy describes how we (“Alphaminr”) collect, use, share and protect your personal information when we provide our service (“Service”). This Privacy Policy explains how information is collected about you either directly or indirectly. By using our service, you acknowledge the terms of this Privacy Notice. If you do not agree to the terms of this Privacy Policy, please do not use our Service. You should contact us if you have questions about it. We may modify this Privacy Policy periodically.
When you register for our Service, we collect information from you such as your name, email address and credit card information.
Like many other websites we use “cookies”, which are small text files that are stored on your computer or other device that record your preferences and actions, including how you use the website. You can set your browser or device to refuse all cookies or to alert you when a cookie is being sent. If you delete your cookies, if you opt-out from cookies, some Services may not function properly. We collect information when you use our Service. This includes which pages you visit.
We use Google Analytics and we use Stripe for payment processing. We will not share the information we collect with third parties for promotional purposes. We may share personal information with law enforcement as required or permitted by law.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Delaware
|
58-1972600
|
|||
|
(State
or other jurisdiction of
|
(I.R.S.
Employer
|
|||
|
incorporation
or organization)
|
Identification
Number)
|
|
Page
|
|||
|
PART
I
|
FINANCIAL
INFORMATION
|
||
|
Item
1.
|
Financial
Statements
|
||
|
Condensed
Consolidated Balance Sheets – March 31, 2010 (unaudited) and December 31,
2009
|
1
|
||
|
Condensed
Consolidated Statements of Operations (unaudited) - Three months ended
March 31, 2010 and 2009
|
2
|
||
|
Condensed
Consolidated Statements of Cash Flows (unaudited) - Three months ended
March 31, 2010 and 2009
|
3
|
||
|
Notes
to Unaudited Condensed Consolidated Financial Statements - March 31,
2010
|
4
|
||
|
Item
2.
|
Management's
Discussion and Analysis of Financial Condition and Results of
Operations
|
9
|
|
|
Item
3.
|
Quantitative
and Qualitative Disclosures about Market Risk
|
11
|
|
|
Item
4.
|
Procedures
and Controls
|
11
|
|
|
PART
II
|
OTHER
INFORMATION
|
||
|
Item
6.
|
Exhibits
|
13
|
|
|
SIGNATURE
PAGE
|
13
|
||
|
EXHIBIT
INDEX
|
14
|
||
|
March 31,
|
December 31,
|
|||||||
|
2010
|
2009
|
|||||||
|
(unaudited)
|
||||||||
|
ASSETS
|
||||||||
|
CURRENT
ASSETS:
|
||||||||
|
Cash
and cash equivalents
|
$ | 56,938 | $ | 58,363 | ||||
|
Marketable
securities
|
23,691 | 24,059 | ||||||
|
Interest
receivable
|
3 | 6 | ||||||
|
Prepaids
and other current assets
|
80 | 667 | ||||||
|
Total
current assets
|
80,712 | 83,095 | ||||||
|
PROPERTY
AND EQUIPMENT, NET
|
637 | 696 | ||||||
|
TOTAL
ASSETS
|
$ | 81,349 | $ | 83,791 | ||||
|
LIABILITIES
AND STOCKHOLDERS' EQUITY
|
||||||||
|
CURRENT
LIABILITIES:
|
||||||||
|
Accounts
payable and accrued liabilities
|
$ | 1,500 | $ | 1,713 | ||||
|
Total
current liabilities
|
1,500 | 1,713 | ||||||
|
Deferred
rent
|
458 | 446 | ||||||
|
Total
liabilities
|
1,958 | 2,159 | ||||||
|
STOCKHOLDERS'
EQUITY
|
||||||||
|
Preferred
stock, $.0001 par value; 5,000,000 shares authorized; none
issued
|
- | - | ||||||
|
Common
stock, $.0001 par value; 100,000,000 shares authorized;
|
||||||||
|
17,441,747
and 17,441,747 shares issued and 17,366,747 and
|
||||||||
|
17,366,747
outstanding in 2010 and 2009, respectively
|
2 | 2 | ||||||
|
Additional
paid-in-capital
|
371,112 | 370,994 | ||||||
|
Accumulated
deficit
|
(291,723 | ) | (289,368 | ) | ||||
|
Treasury
stock, at cost
|
(2 | ) | (2 | ) | ||||
|
Accumulated
other comprehensive gain
|
2 | 6 | ||||||
|
Total
stockholders' equity
|
79,391 | 81,632 | ||||||
|
TOTAL
LIABILITIES AND STOCKHOLDERS' EQUITY
|
$ | 81,349 | $ | 83,791 | ||||
|
THREE MONTHS ENDED
MARCH 31,
|
||||||||
|
2010
|
2009
|
|||||||
|
OPERATING
EXPENSES:
|
||||||||
|
General
and administrative
|
$ | 789 | $ | 923 | ||||
|
Depreciation
|
79 | 89 | ||||||
|
Transaction
costs
|
1,509 | - | ||||||
|
Total
operating expenses
|
2,377 | 1,012 | ||||||
|
OPERATING
LOSS
|
(2,377 | ) | (1,012 | ) | ||||
|
INTEREST
INCOME
|
22 | 411 | ||||||
|
NET
LOSS
|
$ | (2,355 | ) | $ | (601 | ) | ||
|
Loss
per common share:
|
||||||||
|
Basic
|
$ | (0.14 | ) | $ | (0.04 | ) | ||
|
Diluted
|
$ | (0.14 | ) | $ | (0.04 | ) | ||
|
Weighted
average common shares outstanding:
|
||||||||
|
Basic
|
16,867 | 16,867 | ||||||
|
Diluted
|
16,867 | 16,867 | ||||||
|
THREE MONTHS ENDED
MARCH 31,
|
||||||||
|
2010
|
2009
|
|||||||
|
CASH
FLOWS FROM OPERATING ACTIVITIES:
|
||||||||
|
Net
loss
|
$ | (2,355 | ) | $ | (601 | ) | ||
|
Adjustments
to reconcile net loss to net cash used in operating
activities:
|
||||||||
|
Depreciation
on property and equipment
|
79 | 89 | ||||||
|
Amortization
of equity compensation plans
|
118 | 139 | ||||||
|
Amortization
of discount on securities, net
|
(11 | ) | (324 | ) | ||||
|
Changes
in operating assets and liablities:
|
||||||||
|
Decrease/(increase)
in interest receivable, prepaids and other other current
assets
|
590 | (47 | ) | |||||
|
Decrease
in accounts payable and accrued liabilities
|
(213 | ) | (195 | ) | ||||
|
Increase
in deferred rent
|
12 | (1 | ) | |||||
|
NET
CASH USED IN OPERATING ACTIVITIES
|
(1,780 | ) | (940 | ) | ||||
|
CASH
FLOWS FROM INVESTING ACTIVITIES:
|
||||||||
|
Purchase
of marketable securities
|
(9,140 | ) | - | |||||
|
Proceeds
from maturity of marketable securities
|
9,515 | 37,915 | ||||||
|
Purchase
of equipment
|
(20 | ) | (3 | ) | ||||
|
NET
CASH PROVIDED BY INVESTING ACTIVITIES
|
355 | 37,912 | ||||||
|
CASH
FLOWS FROM FINANCING ACTIVITIES:
|
||||||||
| - | - | |||||||
|
NET
CASH PROVIDED BY FINANCING ACTIVITIES
|
- | - | ||||||
|
CHANGE
IN CASH AND CASH EQUIVALENTS
|
(1,425 | ) | 36,972 | |||||
|
CASH
AND CASH EQUIVALENTS, beginning of period
|
58,363 | 19,342 | ||||||
|
CASH
AND CASH EQUIVALENTS, end of period
|
$ | 56,938 | $ | 56,314 | ||||
|
SUPPLEMENTAL
DISCLOSURE:
|
||||||||
|
Cash
paid for franchise and property taxes
|
$ | 250 | $ | 70 | ||||
|
THREE MONTHS ENDED
MARCH 31,
|
||||||||
|
2010
|
2009
|
|||||||
|
BASIC
EARNINGS PER SHARE CALCULATION:
|
||||||||
|
Net
loss
|
$ | (2,355 | ) | $ | (601 | ) | ||
|
Weighted
average common shares - basic
|
16,867 | 16,867 | ||||||
|
Basic
net loss per share
|
$ | (0.14 | ) | $ | (0.04 | ) | ||
|
DILUTED
EARNINGS PER SHARE CALCULATION:
|
||||||||
|
Net
loss
|
$ | (2,355 | ) | $ | (601 | ) | ||
|
Weighted
average common shares - basic
|
16,867 | 16,867 | ||||||
|
Effect
of dilutive stock options
|
- | - | ||||||
|
Effect
of dilutive restricted stock
|
- | - | ||||||
|
Weighted
average common shares - diluted
|
16,867 | 16,867 | ||||||
|
Diluted
net loss per share
|
$ | (0.14 | ) | $ | (0.04 | ) | ||
|
THREE MONTHS ENDED
MARCH 31,
|
||||||||
|
2010
|
2009
|
|||||||
|
Restricted
Stock
|
$ | 67,000 | $ | 67,000 | ||||
|
Stock
Options
|
51,000 | 72,000 | ||||||
|
Total
|
$ | 118,000 | $ | 139,000 | ||||
|
Options
|
Weighted
Average Exercise
Price
|
|||||||
|
Outstanding
at December 31, 2009
|
1,968,750 | $ | 7.01 | |||||
|
Granted
|
- | |||||||
|
Exercised
|
- | |||||||
|
Forfeited
|
- | |||||||
|
Outstanding
at March 31, 2010
|
1,968,750 | $ | 7.01 | |||||
|
Options
exercisable at March 31, 2010
|
1,878,750 | $ | 7.06 | |||||
|
Exercise Price Range
|
Outstanding
|
Exercisable
|
Remaining
Life In Years
|
Weighted
Average
Exercise
Price
|
||||||||||||
|
$3.85
- $ 4.45
|
123,750 | 123,750 | 5.7 | $ | 4.03 | |||||||||||
|
$4.46
- $10.00
|
1,845,000 | 1,755,000 | 5.3 | $ | 6.89 | |||||||||||
|
Total
|
1,968,750 | 1,878,750 | 5.5 | $ | 6.71 | |||||||||||
|
THREE MONTHS ENDED
MARCH 31,
|
||||||||
|
(in thousands)
|
2010
|
2009
|
||||||
|
Net
loss
|
$ | (2,355 | ) | $ | (601 | ) | ||
|
Decrease
in unrealized gain on marketable securities
|
(4 | ) | (302 | ) | ||||
|
Comprehensive
loss
|
$ | (2,359 | ) | $ | (903 | ) | ||
|
Expiration Dates
December 31,
|
Net Operating
Loss
Amount (000's)
|
|||
|
2010
|
$ | 7,417 | ||
|
2011
|
7,520 | |||
|
2012
|
5,157 | |||
|
2020
|
29,533 | |||
|
2021
|
50,430 | |||
|
2022
|
115,000 | |||
|
2023
|
5,712 | |||
|
2024
|
3,566 | |||
|
2025
|
1,707 | |||
|
2026
|
476 | |||
|
2028
|
1,360 | |||
|
2029
|
4,074 | |||
|
2030
|
681 | |||
|
Total
|
232,633 | |||
|
Section 382 Limitation
|
(2,037 | ) | ||
|
After
Limitations
|
$ | 230,596 | ||
|
Number
|
Exhibit
|
|
|
31.1
|
Certification
of Principal Executive Officer pursuant to Section 302 of the
Sarbanes-Oxley Act of 2002.
|
|
|
31.2
|
Certification
of Principal Financial Officer pursuant to Section 302 of the
Sarbanes-Oxley Act of 2002.
|
|
|
32.1
|
Certification
of Principal Executive Officer pursuant to Section 906 of the
Sarbanes-Oxley Act of 2002.
|
|
|
32.2
|
Certification
of Principal Financial Officer pursuant to Section 906 of the
Sarbanes-Oxley Act of
2002.
|
|
/s/ Warren B. Kanders
|
|
|
Warren
B. Kanders,
|
|
|
Executive
Chairman of the Board of Directors
|
|
|
(Principal
Executive Officer)
|
|
|
/s/ Philip A. Baratelli
|
|
|
Philip
A. Baratelli,
|
|
|
Chief
Financial Officer
|
|
|
(Principal
Financial and Chief
|
|
|
Accounting
Officer)
|
|
|
Number
|
Exhibit
|
|
|
31.1
|
Certification
of Principal Executive Officer pursuant to Section 302 of the
Sarbanes-Oxley Act of 2002.
|
|
|
31.2
|
Certification
of Principal Financial Officer pursuant to Section 302 of the
Sarbanes-Oxley Act of 2002.
|
|
|
32.1
|
Certification
of Principal Executive Officer pursuant to Section 906 of the
Sarbanes-Oxley Act of 2002.
|
|
|
32.2
|
Certification
Principal Financial Officer pursuant to Section 906 of the Sarbanes-Oxley
Act of 2002.
|
No information found
* THE VALUE IS THE MARKET VALUE AS OF THE LAST DAY OF THE QUARTER FOR WHICH THE 13F WAS FILED.
| FUND | NUMBER OF SHARES | VALUE ($) | PUT OR CALL |
|---|
| DIRECTORS | AGE | BIO | OTHER DIRECTOR MEMBERSHIPS |
|---|
No information found
No Customers Found
No Suppliers Found
Price
Yield
| Owner | Position | Direct Shares | Indirect Shares |
|---|